Clonal Hematopoiesis More Prevalent in Pediatric Cancer Survivors
Survivors of pediatric cancer have a higher rate of clonal hematopoiesis than their peers at any age, a study suggests.
Diagnosis & Disease Information
Location of KIT Mutations Impacts Response to TKIs in Patients With GIST
The location of KIT mutations is associated with response to ripretinib and sunitinib in patients with previously treated GIST, research suggests.
Larotrectinib Bests Standard Care for TRK-Fusion Positive Cancers
Larotrectinib prolongs survival when compared with non-TRK inhibitor standard care in adults with TRK fusion-positive cancers, a study suggests.
Ganitumab Provides No Benefit in Metastatic Ewing Sarcoma
Adding ganitumab to standard chemotherapy does not provide a benefit for patients with metastatic Ewing sarcoma, a phase 3 trial suggests.
AYAs With Hematologic Malignancies Have Higher Risk of Early Death
The risk of early death in AYAs with cancer depends on the type of malignancy they have as well as multiple demographic factors, a study suggests.
Tecentriq Approved for Unresectable or Metastatic Alveolar Soft Part Sarcoma
The approval was based on data from a phase 2 study that included 49 patients with unresectable or metastatic ASPS.
Kaposi Sarcoma Incidence Increasing in Black Men, Decreasing in White Men
The incidence of Kaposi sarcoma is increasing among Black men and decreasing among White men in the United States, a study suggests.
Shorter Regimen of Radiotherapy Safe for Soft Tissue Sarcoma
None of the patients had grade 3 or higher acute radiation toxicity.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Predicting the Risk of Thoracic Soft Tissue Sarcoma After Breast Cancer
There are several factors that may increase the risk of thoracic soft tissue sarcoma in patients with a history of breast cancer.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...